 | |
- close
- close
|
StreetInsider.com
Nov 6
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Smith+%26+Nephew+%28SNN%29+Posts+Q3+EPS+of+%240.34%2C+Misses+Views/5082365.html for the full story.
Financial Times
Nov 6
Comment
The medical device equipment supplier offered a cautious outlook even as pre-tax profits rose 45% in the three months to the end of September
MarketWatch
Nov 6
Comment
Orthopedics firm Smith & Nephew said Friday that its third-quarter net profit rose to $128 million, from $74 million last year. Revenue declined to $915 million, from $930 million a year ago, hit by adverse currency movements. "Market conditions...
Marketwire
Nov 6
Comment
LONDON -- (Marketwire) -- 11/06/09 -- Smith & Nephew Q3 Results - continued strong profit performance 6 November 2009 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the third quarter ended
Marketwire
Nov 3
Comment
London, UK -- (Marketwire) -- 11/03/09 -- Smith & Nephew plc 3 November 2009 Smith & Nephew plc - Transaction in Own Shares Smith & Nephew plc announces that on 2 November 2009 it transferred a total of 571,733 ordinary shares of USD0.20 each to
Marketwire
Oct 30
Comment
London, UK -- (Marketwire) -- 10/30/09 -- Smith & Nephew plc - Voting Rights and Capital 30 October 2009 In conformity with Rule 5.6.1 of the FSA's Disclosure and Transparency Rules, we notify the market that as at 30 October 2009: Smith & Nephew
PR Newswire
Oct 29
Comment
MEMPHIS, Tenn., Oct. 29 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Orthopaedics business announced today it has made a first-of-its-kind contribution to the Center for Orthopaedic Trauma Advancement (COTA) for fellowship and
Marketwire
Oct 26
Comment
LONDON -- (Marketwire) -- 10/26/09 -- RIS Announcement -Award purchase Smith & Nephew Plc ("the Company") Employee Share Plans - Announcement of transaction in American Depository Shares (ADSs) representing five ordinary shares of USD0.20 each. SMITH
PR Newswire
Oct 23
Comment
ST. PETERSBURG, Fla., Oct. 23 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), highlighted the results of a multi-center study which demonstrates that
PR Newswire
Oct 22
Comment
ST. PETERSBURG, Fla., Oct. 22 /PRNewswire-FirstCall/ -- The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), announced today that clinicians will present a total of 20 clinical
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSISTOP CONTRIBUTORS
SNN AT A GLANCE
Smith & Nephew (NYSE:SNN) is a global medical devices business engaged in orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management having revenue of over $2.7 billion in 2006. It is an English public limited company with its shares listed on the official list of the UK Listing Authority and it is traded on the London Stock Exchange and on the New York Stock Exchange in the form of ADSs. [1] Smith & Nephew primarily competes with Stryker (SYK), JOHNSON & JOHNSON (JNJ)’s DePuy subsidiary, Zimmer Holdings (ZMH) , and Biomet (BMET).
Business Overview
Smith & Nephew operates in three main market segments: Orthopaedic Reconstruction, Trauma and Clinical Therapies, Endoscopy, and Advanced Wound Management
- Orthopaedic Reconstruction: Reconstruction implants include hip, knee and shoulder joints as well as ancillary products such as bone cement and mixing systems used in cemented reconstruction joint surgery. The reconstruction business is managed worldwide from Memphis, Tennessee, which also houses its main manufacturing facility. [2]
- Trauma and Clinical Therapies: Trauma products consist of internal and external fixation devices and orthobiological materials used in the stabilization of severe fractures and deformity correction procedures and clinical therapies consist of products used in the areas of bone growth stimulation and joint fluid therapy.[3]
- Endoscopy: Smith & Nephew’s endoscopy business, headquartered in Andover, Massachusetts, develops and commercializes endoscopic techniques, educational programs and value-added services for surgeons to treat and repair soft tissue. The business focuses principally on arthroscopy, minimally invasive surgery of the knee, shoulder and hip joints.[4]
- Advanced Wound Management: Smith & Nephew’s advanced wound management business is headquartered in Hull, England and offers a range of products from initial wound bed preparation through full wound closure. These products are targeted particularly at chronic wounds connected with the older population, such as pressure sores and venous leg ulcers, burns and complex surgical wounds.[5]
References
- ↑ SNN 2006 20f, Pg 1
- ↑ SNN 2006 20f, Pg 4
- ↑ SNN 2006 20f, Pg 7
- ↑ SNN 2006 20f, Pg 9
- ↑ SNN 2006 20f, Pg 11
| ||||||
|
|
